MYP_039913
Basic Information
CPEM
Anticancer Cytotoxic anticancer activity Cytotoxic
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Toxicity / Safety Cytotoxicity Cytotoxic
Venom / Toxin General toxin Cytotoxic
Standard
7 amino acids
C38H59N7O10S2
Standard
Sequence
CPEVFLM
Physicochemical Analysis
838.05 Da
4.05
-1.25
-1.47
-0.1781
1.44
0.19
0.52
60.91
97.14
0.1429
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
266.43
0.31
9.0
11.0
24.0
57.0
2.0
6.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0344414 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization
Cyclization
Bio-Activity Profile
Antimicrobial Antiviral
inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells
200 μM
IC50
RECORD: Rec_0423381 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
cyclic peptide architecture [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization (N termini to C termini)
Cyclization (N termini to C termini)
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells
200 μM
IC50
Mammalian: 1.2 h; Yeast: >20 h; E. coli: >10 h
Showing 2 records on this page · Page 2 of 2